Nonprescription diet pill alli back in stores after recall

(AP)—GlaxoSmithKline's diet pill, alli (ow-LEYE'), is now back in most U.S. stores.

The British drugmaker voluntary recalled the product last March after finding some packages in stores didn't contain real alli, indicating tampering after shipment. The Food and Drug Administration is still investigating.

Glaxo's innovation center for consumer products, in Parsippany, New Jersey, says the product package was redesigned to make tampering easier to spot.

Before shipping alli, known chemically as orlistat, to retail stores, Glaxo launched it in mid-February through and other online retailers. Since late January, it's been available for preorders on, where Glaxo says it was the top-selling diet item during the first pre-order week.

GlaxoSmithKline says alli is the only nonpresciption diet medicine approved in the U.S. that's proven to help people lose weight.

Explore further

FDA probes liver damage with weight loss pill alli

© 2015 The Associated Press. All rights reserved.

Citation: Nonprescription diet pill alli back in stores after recall (2015, February 25) retrieved 18 November 2019 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments